|
| Status |
Public on Jul 15, 2014 |
| Title |
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
28344039 |
| Submission date |
Jul 01, 2014 |
| Last update date |
Oct 24, 2019 |
| Contact name |
Xiaoju Wang |
| E-mail(s) |
xiaojuw@umich.edu
|
| Phone |
734-763-6056
|
| Organization name |
University of Michigan
|
| Street address |
1500 E. Medical Center Drive
|
| City |
Ann Arbor |
| State/province |
MI |
| ZIP/Postal code |
48109 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL4133 |
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (6)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE58939 |
Development of peptidomimetic inhibitors of the ERG transcription factor in prostate cancer (ChIP-seq) |
| GSE58940 |
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer (expression) |
|
| Relations |
| BioProject |
PRJNA254030 |
Less...
More...